CENTRALIZED CHEMOPREVENTIVE AGENT REPOSITORY AND DRUG CHEMISTRY SUPPORT

NCI的癌症预防部门(DCP)维持着一项药物开发计划，以支持将有望预防或减少癌症的实验室发现转化为有效的医疗干预措施。 实施这一计划所需的服务是多样化和高度专业化的。这需要一种多才多艺的运作方式，能够为体外和体内的临床前疗效评估、癌症预防部门的快速预防干预开发(RAPID)计划、临床前毒理学研究和人体临床试验提供药剂。 该资料库集中提供支持化学预防研究所需的药剂和开发服务。该仓库为化学预防研究的研究试剂的获取、跟踪、储存、维护、测试、质量控制和分配提供了重要的后勤组织。

The Division of Cancer Prevention (DCP), NCI, maintains a pharmaceutical development program to support the translation of promising laboratory discoveries for the prevention or reduction of cancer into effective medical interventions. The services required to implement this program are diverse and highly specialized. This requires a versatile operation capable of supplying agents for in-vitro and in-vivo pre-clinical efficacy evaluations, development services for the Division of Cancer Prevention's Rapid Access to Preventive Intervention Development (RAPID) program, pre-clinical toxicology studies and human clinical trials. The Repository maintains a centralized source of agents and development services necessary to support chemoprevention studies. The repository provides important logistic organization for the acquisition, tracking, storage, maintenance, testing, quality control, and distribution of investigational agents for the study of chemoprevention.